Sign in
4

Changes in Ownership

Eton Pharmaceuticals, Inc. Filed Acc 0001493152-22-005605

Options or other derivatives

  • President & CEO acquired 416,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BRYNJELSEN SEAN · President & CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-07 Grant or award : show line 1 in the form Stock Option(Right to buy) +416,500 1,601,500 D
Loading xslF345X03/ownership.xml…